ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 80 filers reported holding ORCHARD THERAPEUTICS PLC in Q3 2021. The put-call ratio across all filers is 4.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $6,790 | -81.1% | 18,301 | -74.4% | 0.00% | – |
| Q3 2022 | $36,000 | -28.0% | 71,503 | -16.9% | 0.00% | – |
| Q2 2022 | $50,000 | -26.5% | 86,055 | -10.1% | 0.00% | – |
| Q1 2022 | $68,000 | +25.9% | 95,749 | +130.8% | 0.00% | – |
| Q4 2021 | $54,000 | -47.6% | 41,479 | -7.3% | 0.00% | – |
| Q3 2021 | $103,000 | +151.2% | 44,739 | +382.0% | 0.00% | – |
| Q2 2021 | $41,000 | -86.9% | 9,281 | -78.5% | 0.00% | – |
| Q1 2021 | $314,000 | +3388.9% | 43,078 | +1871.5% | 0.00% | – |
| Q4 2020 | $9,000 | -98.9% | 2,185 | -99.0% | 0.00% | – |
| Q3 2020 | $857,000 | -6.2% | 208,492 | +37.0% | 0.00% | – |
| Q2 2020 | $914,000 | -15.7% | 152,197 | +5.7% | 0.00% | – |
| Q1 2020 | $1,084,000 | -38.9% | 144,005 | +11.7% | 0.00% | – |
| Q4 2019 | $1,773,000 | +5.4% | 128,964 | -8.9% | 0.00% | – |
| Q3 2019 | $1,682,000 | – | 141,525 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 5,307,751 | $3,101,000 | 1.18% |
| TANG CAPITAL MANAGEMENT LLC | 2,000,000 | $1,168,000 | 0.18% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $4,060,000 | 0.08% |
| Artal Group S.A. | 1,803,858 | $1,054,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 616,402 | $360,000 | 0.05% |
| RA Capital Management | 3,040,885 | $1,776,000 | 0.05% |
| Forefront Analytics, LLC | 92,641 | $58,000 | 0.03% |
| Temasek Holdings (Private) Ltd | 4,319,049 | $2,523,188 | 0.01% |
| FEDERATED HERMES, INC. | 8,309,859 | $4,853,000 | 0.01% |
| Cormorant Asset Management, LP | 256,649 | $150,000 | 0.01% |